We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Woodside Energy
WDS
$42.6B
| $94.2K | 0.01% |
4,061
+194
| +5% | +$4.44K |
|
|
ORAN
502
DELISTED
Orange
ORAN
| $94K | 0.01% |
8,075
+270
| +3% | +$3.28K |
|
503
J.M. Smucker
SJM
$12.8B
| $93.5K | 0.01% |
633
-100
| -14% | -$15.3K |
|
504
Cheesecake Factory
CAKE
$5.33B
| $92.9K | 0.01% |
2,685
+16
| +0.6% | +$530 |
|
505
PPG Industries
PPG
$26.6B
| $92.8K | 0.01% |
626
-15
| -2% | -$2.09K |
|
506
Invesco Solar ETF
TAN
$1.38B
| $92.4K | 0.01% |
1,294
+1,161
| +873% | +$83.8K |
|
507
Scotiabank
BNS
$108B
| $92.4K | 0.01% |
1,846
+656
| +55% | +$32.5K |
|
508
Kimco Realty
KIM
$16.4B
| $91.9K | 0.01% |
4,662
+232
| +5% | +$4.37K |
|
509
CMS Energy
CMS
$22.3B
| $91.7K | 0.01% |
1,561
+66
| +4% | +$3.98K |
|
510
ResMed
RMD
$30.7B
| $91.3K | 0.01% |
418
-17
| -4% | -$3.79K |
|
511
Tractor Supply
TSCO
$18B
| $91.3K | 0.01% |
2,065
-140
| -6% | -$6.42K |
|
512
Halliburton
HAL
$26.6B
| $91.2K | 0.01% |
2,764
+825
| +43% | +$26.1K |
|
513
Trip.com Group
TCOM
$29.1B
| $90.6K | 0.01% |
2,588
+899
| +53% | +$31.3K |
|
514
Archer Daniels Midland
ADM
$36.9B
| $90.3K | 0.01% |
1,195
-459
| -28% | -$34.7K |
|
515
Takeda Pharmaceutical
TAK
$55.7B
| $90.2K | 0.01% |
5,743
-1,737
| -23% | -$28.5K |
|
516
NetApp
NTAP
$37.2B
| $89.8K | 0.01% |
1,175
+193
| +20% | +$13K |
|
517
iShares Silver Trust
SLV
$30.9B
| $89.6K | 0.01% |
+4,290
| New | +$95.4K |
|
518
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $88.8K | 0.01% |
1,183
| – | – |
|
519
RELX
RELX
$62B
| $88.7K | 0.01% |
2,652
-196
| -7% | -$6.31K |
|
520
International Flavors & Fragrances
IFF
$21.9B
| $88.6K | 0.01% |
1,113
+1,023
| +1,137% | +$88K |
|
521
ProShares UltraPro Short Dow 30
SDOW
$183M
| $88.3K | 0.01% |
925
+175
| +23% | +$17.9K |
|
522
Raymond James Financial
RJF
$34B
| $88.2K | 0.01% |
850
+87
| +11% | +$8.08K |
|
523
Cognex
CGNX
$11.3B
| $87.9K | 0.01% |
1,569
+32
| +2% | +$1.66K |
|
524
Genuine Parts
GPC
$18.7B
| $87.8K | 0.01% |
519
-30
| -5% | -$4.91K |
|
525
EastGroup Properties
EGP
$10.9B
| $87.5K | 0.01% |
504
+2
| +0.4% | +$334 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.